Zhaoxia Tan

995 total citations
27 papers, 353 citations indexed

About

Zhaoxia Tan is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zhaoxia Tan has authored 27 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Hepatology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zhaoxia Tan's work include Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Zhaoxia Tan is often cited by papers focused on Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Zhaoxia Tan collaborates with scholars based in China, United States and Hong Kong. Zhaoxia Tan's co-authors include Guohong Deng, Xiaomei Xiang, Rentao Yu, Yunjie Dan, Fan Yi, Zehui Yan, Yu‐Ming Wang, Wenting Tan, Yi Zhou and Yaokai Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Virology.

In The Last Decade

Zhaoxia Tan

25 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoxia Tan China 11 180 170 63 54 39 27 353
Yuta Wakui Japan 13 199 1.1× 276 1.6× 41 0.7× 33 0.6× 88 2.3× 23 467
Zhiliang Gao China 13 303 1.7× 311 1.8× 66 1.0× 43 0.8× 104 2.7× 59 520
Nungki Anggorowati Indonesia 12 102 0.6× 111 0.7× 52 0.8× 19 0.4× 45 1.2× 36 298
Ernesto Claar Italy 8 165 0.9× 136 0.8× 46 0.7× 24 0.4× 31 0.8× 16 313
Jin Ye China 8 297 1.6× 283 1.7× 37 0.6× 34 0.6× 122 3.1× 18 575
Leila Maria Moreira Beltrão Pereira Brazil 9 237 1.3× 251 1.5× 26 0.4× 16 0.3× 31 0.8× 19 385
Yuqiang Mi China 11 223 1.2× 356 2.1× 30 0.5× 19 0.4× 69 1.8× 50 474
Klára Werling Hungary 9 115 0.6× 154 0.9× 24 0.4× 36 0.7× 59 1.5× 43 315
Θεόδωρος Ανδρουτσάκος Greece 10 145 0.8× 239 1.4× 46 0.7× 12 0.2× 61 1.6× 36 390

Countries citing papers authored by Zhaoxia Tan

Since Specialization
Citations

This map shows the geographic impact of Zhaoxia Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoxia Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoxia Tan more than expected).

Fields of papers citing papers by Zhaoxia Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoxia Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoxia Tan. The network helps show where Zhaoxia Tan may publish in the future.

Co-authorship network of co-authors of Zhaoxia Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoxia Tan. A scholar is included among the top collaborators of Zhaoxia Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoxia Tan. Zhaoxia Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ying, Ying Zhu, Yi Zhou, et al.. (2025). Anti-HBc IgM associates with acute flare and HBeAg/HBsAg loss in chronic hepatitis B patients with acute exacerbation. Virulence. 16(1). 2534078–2534078.
2.
Liu, Huimin, Zhaoxia Tan, Lishan Ran, et al.. (2025). Short-term pegylated interferon alpha in chronic HBV patients with ultra-low HBsAg: a retrospective study. Frontiers in Cellular and Infection Microbiology. 15. 1582997–1582997.
3.
Cui, Ying, et al.. (2023). Cardiopulmonary bypass for total aortic arch replacement surgery: A review of three techniques. Frontiers in Cardiovascular Medicine. 10. 1109401–1109401. 2 indexed citations
4.
Sun, Shuning, Baoyan Xu, Wenting Tan, et al.. (2021). Testosterone and Estradiol as Novel Prognostic Indicators for HBV-Related Acute-on-Chronic Liver Failure. Frontiers in Medicine. 8. 729030–729030. 7 indexed citations
5.
Xu, Baoyan, Qiao Yang, Zhaoxia Tan, et al.. (2021). SIX1/EYA1 are novel liver damage biomarkers in chronic hepatitis B and other liver diseases. Annals of Translational Medicine. 9(12). 992–992. 2 indexed citations
6.
Tan, Zhaoxia, et al.. (2020). Total body retrograde perfusion during hypothermic circulatory arrest is unsafe. Perfusion. 35(7). 707–709. 2 indexed citations
7.
Yu, Rentao, Yunjie Dan, Yanqiu Lu, et al.. (2020). Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection. Virology. 553. 131–134. 14 indexed citations
8.
9.
Yu, Hong, Qi Li, Chan Chen, et al.. (2018). Effect of intralipid on myocardial injury during valve replacement surgery with concomitant radiofrequency ablation. Medicine. 97(1). e9603–e9603. 3 indexed citations
10.
Lin, Jing, et al.. (2018). Combining Cerebral Perfusion With Retrograde Inferior Vena Caval Perfusion for Aortic Arch Surgery. The Annals of Thoracic Surgery. 107(1). e67–e69. 10 indexed citations
11.
Zhou, Ronghua, Hui Yu, Hui Yu, et al.. (2017). Effect of intralipid postconditioning on myocardial injury in patients undergoing valve replacement surgery: a randomised controlled trial. Heart. 103(14). 1122–1127. 10 indexed citations
12.
Yu, Rentao, Zhaoxia Tan, Xiaomei Xiang, Yunjie Dan, & Guohong Deng. (2017). Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data. BMC Cancer. 17(1). 608–608. 66 indexed citations
13.
Yu, Rentao, Xiaomei Xiang, Zhaoxia Tan, et al.. (2016). Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients. Scientific Reports. 6(1). 35050–35050. 22 indexed citations
14.
Tan, Zhaoxia, Li Zhou, Zhen Qin, et al.. (2016). Low-Dose Sevoflurane May Reduce Blood Loss and Need for Blood Products After Cardiac Surgery. Medicine. 95(17). e3424–e3424. 4 indexed citations
15.
Yu, Rentao, Wenting Tan, Zhaoxia Tan, et al.. (2015). Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population. Hepatitis Monthly. 15(7). e28806–e28806. 26 indexed citations
16.
17.
Tan, Zhaoxia, et al.. (2014). Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection. Journal of Clinical Virology. 59(4). 228–234. 8 indexed citations
18.
Zhu, Peng, et al.. (2013). Expression Pattern of Serum Cytokines in Hepatitis B Virus Infected Patients with Persistently Normal Alanine Aminotransferase Levels. Journal of Clinical Immunology. 33(7). 1240–1249. 22 indexed citations
19.
Tan, Zhaoxia, et al.. (2011). [The velocity of HCV subtype 6a transmission in southwest China].. PubMed. 19(7). 502–5. 1 indexed citations
20.
Wang, Xiaohong, et al.. (2010). Natural intragenotypic and intergenotypic HCV recombinants are rare in southwest China even among patients with multiple exposures. Journal of Clinical Virology. 49(4). 272–276. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuta Wakui Breakdown of academic impact, for papers by Zhiliang Gao Breakdown of academic impact, for papers by Nungki Anggorowati Breakdown of academic impact, for papers by Ernesto Claar Breakdown of academic impact, for papers by Jin Ye Breakdown of academic impact, for papers by Leila Maria Moreira Beltrão Pereira Breakdown of academic impact, for papers by Yuqiang Mi Breakdown of academic impact, for papers by Klára Werling Breakdown of academic impact, for papers by Θεόδωρος Ανδρουτσάκος
Rankless by CCL
2026